In Nigeria’s challenging economic environment, healthcare—particularly pharmaceuticals—remains one of the few sectors insulated from discretionary spending cycles. Medicines are consumed regardless of economic conditions, making pharmaceutical demand structurally resilient across booms and downturns. From antimalarials and antibiotics to chronic-care and over-the-counter drugs, consumption persists even as household incomes come under pressure. This reality positions pharmaceutical … Continue reading Pharmaceutical Stocks On NGX: A Closer Look At Fidson, May & Baker, Neimeth And MeCure In 2026